
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
[ Mon, Feb 05th 2024 ]: WOPRAI
Sung Ji Nam Maintained (TWST) at Buy with Increased Target to $43 on, Feb 5th, 2024


🞛 This publication is a summary or evaluation of another publication
Sung Ji Nam of Scotiabank, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Increased Target from $30 to $43 on, Feb 5th, 2024.
Sung has made no other calls on TWST in the last 4 months.
There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, 0 agree with Sung's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Sung
- Luke Sergott of "Barclays" Maintained at Buy with Increased Target to $45 on, Thursday, January 25th, 2024
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $45 on, Thursday, January 18th, 2024